![Expression of MHC II, B-cell markers, and plasma cell markers in DLBCL.... | Download Scientific Diagram Expression of MHC II, B-cell markers, and plasma cell markers in DLBCL.... | Download Scientific Diagram](https://www.researchgate.net/publication/51876829/figure/fig4/AS:305717790691333@1449900209743/Expression-of-MHC-II-B-cell-markers-and-plasma-cell-markers-in-DLBCL-Chromogenic-IHC.png)
Expression of MHC II, B-cell markers, and plasma cell markers in DLBCL.... | Download Scientific Diagram
![MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ–independent fashion and during development | Scientific Reports MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ–independent fashion and during development | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep24251/MediaObjects/41598_2016_Article_BFsrep24251_Fig1_HTML.jpg)
MHC-class-II are expressed in a subpopulation of human neural stem cells in vitro in an IFNγ–independent fashion and during development | Scientific Reports
![IJMS | Free Full-Text | MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It IJMS | Free Full-Text | MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It](https://www.mdpi.com/ijms/ijms-22-06741/article_deploy/html/images/ijms-22-06741-g001.png)
IJMS | Free Full-Text | MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
![The MHC class I dependent antigen-presentation pathway. Intracellular... | Download Scientific Diagram The MHC class I dependent antigen-presentation pathway. Intracellular... | Download Scientific Diagram](https://www.researchgate.net/publication/330762964/figure/fig1/AS:960055813885970@1605906551196/The-MHC-class-I-dependent-antigen-presentation-pathway-Intracellular-antigenic-peptides.png)
The MHC class I dependent antigen-presentation pathway. Intracellular... | Download Scientific Diagram
![MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts: Trends in Molecular Medicine MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/582694/4392257/gr1.jpg)
MHC–peptide specificity and T-cell epitope mapping: where immunotherapy starts: Trends in Molecular Medicine
![IBA Lifesciences MHC I-Strep HLA-A*0201; Influenza M (GILGFVFTL) Capacity: 40μL Secondary Antibody Staining Reagents | Fisher Scientific IBA Lifesciences MHC I-Strep HLA-A*0201; Influenza M (GILGFVFTL) Capacity: 40μL Secondary Antibody Staining Reagents | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/CCG/IBA-Solutions-For-Life-Science/product-images/6-7003-001.jpg-650.jpg)
IBA Lifesciences MHC I-Strep HLA-A*0201; Influenza M (GILGFVFTL) Capacity: 40μL Secondary Antibody Staining Reagents | Fisher Scientific
![MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration | Nature Communications MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncomms4633/MediaObjects/41467_2014_Article_BFncomms4633_Fig1_HTML.jpg)